although the FDA will potentially have more money in the long run, the delay in negotiation for a new deal will cause “substantial layoffs at the [FDA]” as the article Alexandra posted stated. this will definitely slow down review time for devices. I also agree with akashranpura that there will be a monopolizing effect. However if the smaller companies just get bought the products they’re creating still have a chance to make it to market. However, as DH239 stated, many companies may also go under, which ultimately hinders innovation in the medical device industry. this proposed fee increase seems to have a negative impact on everyone.

http://www.fiercehealthcare.com/regulatory/trump-s-budget-would-increase-user-fees-for-digital-health-companies-seeking-fda